| Literature DB >> 31757732 |
Sandrine Perol1, Justine Hugon-Rodin1, Geneviève Plu-Bureau2.
Abstract
Hypertension is a major risk factor for cardiovascular diseases. Because of the high frequency of hormonal contraceptives use, assessing their side effects is an important public health issue. In this perspective, we conducted a review of the risk of hypertension associated with the use of hormonal contraceptives, either combined estrogen-progestin or only progestin. The use of combined hormonal contraceptives, regardless of its type and route of administration, is associated with a slight increase in blood pressure, both systolic and diastolic blood pressures. The frequency of onset of hypertension in women who use combined hormonal contraception is between 0.6% and 8.5%. Progestin-only contraception seems safe with respect to the risk of hypertension. It is therefore important to remember that the use of combined hormonal contraception is contra-indicated in hypertensive women, even well controlled. Finally, we propose a prescription assistance algorithm according to the recommendations of an expert panel. It should be remembered that taking blood pressure at each contraceptive consultation (initial and follow-up) is essential.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31757732 DOI: 10.1016/j.lpm.2019.07.033
Source DB: PubMed Journal: Presse Med ISSN: 0755-4982 Impact factor: 1.228